Detection and significance of TregFoxP3+and Th17 cells in peripheral blood of non-small cell lung cancer patients

Archives of Medical Science

Volumn 10, Issue 2, 2014, Pages 232-239

  Li, Sha ^a   Li, Yan ^a   Qu, Xun ^b   Liu, Xiaolin ^a   Liang, Jing ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Carcinoma; Non small cell lung; ROR t; Th17

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; REGULATORY T LYMPHOCYTE FOXP3+; TH17 CELL;

EID: 84901012496     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.42573     Document Type: Article

References (22)

1. Ghayumi MA, Mojtahedi Z, Fattahi MJ, Fattahi MJ. Th1 and Th2 cytokine profiles in malignant pleural effusion. Iran J Immunol 2011; 8: 195-200.
2. Shao Q, Ning H, Lv J, et al. Regulation of Th1/Th2 polarization by tissue inhibitor of metalloproteinase-3 via modulating dendritic cells. Blood 2012; 119: 4636-44.
3. Li J, Diao H, Zhao D, et al. Reduced tumourigenicity of EG7 after RANTES gene transfer and the underlying mechanism. Arch Med Sci 2010; 6: 829-36.
4. Chen D, Huang X, Yang M, Gan H, Gunawan EJ, Tang W. Treg/Th17 Functional disequilibrium in Chinese uremia on hemodialysis: a link between calcification and cardiovascular disease. Renal Failure 2012; 34: 697-702.
5. Fu HY, Li C, Yang W, et al. FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: implications for tumor progression and escape. Acta Histochem 2013; 115: 151-7.
6. Wang W, Hodkinson P, McLaren F, et al. Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate. Int J Cancer 2012; 131: E928-37.
7. Maruyama T, Kono K, Mizukami Y, et al. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 2010; 101: 1947-54.
8. Kesselring R, Thiel A, Pries R, et al. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development. Br J Cancer 2010; 103: 1245-54.
9. Kim C, Cadet P. Environmental toxin 4-nonylphenol and autoimmune diseases: using DNA microarray to examine genetic markers of cytokine expression. Arch Med Sci 2010; 3: 321-7.
10. Ciebiada M, Kasztalska K, Gorska-Ciebiada M, Barylski M, Gorski P. Expression of IL-7 receptor in human peripheral regulatory T cells. Arch Med Sci 2013; 9: 555-60.
11. Shimizu K, Nakata M, Hirami Y, Yukawa T, Maeda A, Tanemoto K. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol 2010; 5: 585-90.
12. Lord JD, Hackman RC, Gooley TA, et al. Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease. Biol Blood Marrow Transplant 2011; 17: 486-96.
13. Kulach A, Dabek J, Wilczok T, et al. Changes in transforming growth factor beta; and its receptors'mRNA expression in monocytes from patients with acute coronary syndromes. Arch Med Sci 2010; 5: 526-38.
14. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGF-beta in the context of an inflammatory cytokine Milieu supports de novo differentiation of IL17-producing T vells. Immunity 2006; 24: 179-83.
15. Teng MW, von Scheidt B, Duret H, Towne JE, Smyth MJ. Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases. Cancer Res 2011; 71: 2077-86.
16. Hirota K, Duarte JH, Veldhoen M, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nature Immunol 2011; 12: 255-63.
17. Martin-Orozco N, Muranski P, Chung Y, et al. T Helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009; 31: 787-98.
18. Xu L, Wang C, Wen Z, et al. CpG Oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells. Clin Dev Immunol 2010; 2010: 410893.
19. Ankathatti Munegowda M, Deng Y, Mulligan SJ, Xiang J. Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunol Immunother 2011; 60: 1473-84.
20. Tao H, Mimura Y, Aoe K, et al. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer 2012; 75: 95-101.
21. Chi LJ, Lu HT, Li GL, et al. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol 2010; 161: 480-9.
22. Kennedy CL, Najdovska M, Jones GW, et al. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17. J Pathol 2011; 225: 255-64.